Violet - Colored Inguinal Located Cutaneous Tumour? by Tchernev, Georgi et al.
 
Open Access Maced J Med Sci electronic publication ahead of print,  
published on January 13, 2018 as https://doi.org/10.3889/oamjms.2018.015 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci.                                                                                                                                                                                                          1 
 
ID Design Press, Skopje, Republic of Macedonia 
Open Access Macedonian Journal of Medical Sciences. 
Special Issue: Global Dermatology-2 
https://doi.org/10.3889/oamjms.2018.015 
eISSN: 1857-9655 
Case Report 
 
 
  
 
Violet - Colored Inguinal Located Cutaneous Tumour? 
 
 
Georgi Tchernev
1,2*
, Anastasiya Atanasova Chokoeva
3
, Torello Lotti
4
, Uwe Wollina
5
, Irina Yungareva
1
, Ilia Lozev
6
, Georgi 
Konstantinov Maximov
2 
 
1
Medical Institute of Ministry of Interior (MVR), Department of Dermatology, Venereology and Dermatologic Surgery, Sofia, 
Bulgaria; 
2
”Onkoderma” - Policlinic for Dermatology and Dermatologic Surgery, Sofia, Bulgaria; 
3
Medical University Plovdiv, 
Dermatology and Venereology, Vasil Aprilov 15A, Plovdiv 4000, Bulgaria; 
4
University G. Marconi of Rome - Dermatology 
and Venereology, Rome, Italy; 
5
Städtisches Klinikum Dresden - Department of Dermatology and Allergology, Dresden, 
Sachsen, Germany;  
6
Medical Institute of Ministry of Interior Department of General, Vascular and Abdominal Surgery, Sofia, 
Bulgaria 
 
Citation: Tchernev G, Chokoeva AA, Lotti T, Wollina U, 
Yungareva I, Lozev I, Maximov GK. Violet - Colored 
Inguinal Located Cutaneous Tumour? Open Access 
Maced J Med Sci. 
https://doi.org/10.3889/oamjms.2018.015 
Keywords: B cell lymphoma; T cell lymphoma; anaplastic 
large; surgery; chemotherapy; systemic involvement 
*Correspondence: Georgi Tchernev. Department of 
Dermatology, Venereology and Dermatologic Surgery, 
Medical Institute of Ministry of Interior (MVR-Sofia), 
General Skobelev 79, 1606 Sofia, Bulgaria; Onkoderma - 
Policlinic for Dermatology, Venereology and Dermatologic 
Surgery, General Skobelev 26, 1606, Sofia, Bulgaria. E-
mail: georgi_tchernev@yahoo.de 
Received: 31-Jul-2017; Revised: 01-Sep-2017; 
Accepted: 03-Sep-2017; Online first: 13-Jan-2018 
Copyright: © 2018 Georgi Tchernev, Anastasiya 
Atanasova Chokoeva, Torello Lotti, Uwe Wollina, Irina 
Yungareva, Ilia Lozev, Georgi Konstantinov Maximov. 
This is an open-access article distributed under the terms 
of the Creative Commons Attribution-NonCommercial 4.0 
International License (CC BY-NC 4.0) 
Funding: This research did not receive any financial 
support 
Competing Interests: The authors have declared that no 
competing interests exist 
 
 
Abstract  
Anaplastic large cell lymphoma (ALCL) represents an aggressive CD30 – positive T cell lymphoma, as it is the 
second most common T cell lymphoma and 2% to 5% of all non - Hodgkin lymphomas. The cutaneous 
involvement can be primary or secondary within systemic ALCL, resembling inflammatory and other neoplastic 
lesions both clinically and cytologically. Various pigmented cutaneous tumours with a different origin, cutaneous 
metastasis and B-cell lymphoma must be carefully considered in the differential diagnostic plan. While simple 
surgical excision is usually curative, with good prognosis, systemic involvement must also be excluded. We 
present a case of a patient, with clinically unspecific single violet nodular lesion, as the only clinical manifestation 
of ALCL. The diagnosis was confirmed histologically, as the surgical excision was enough therapeutic 
management, regarding the early disease stage. Further following up with the patient is mandatory, because of 
the high recurrence rate. We want to emphasise the diversity of clinical manifestation of ALCL, regarding the 
importance of its early diagnosis and treatment. 
 
 
 
 
 
 
 
 
Introduction 
 
 Anaplastic large cell lymphoma (ALCL) is the 
second most common T cell lymphoma and 2% to 5% 
of all non-Hodgkin lymphomas [1][2]. It represents an 
aggressive CD30 - positive T - cell lymphoma, with 
three subtypes, exhibiting a chromosomal 
translocation involving the ALK gene and the 
expression of ALK protein [3]. Although no current risk 
factors have been identified, some studies have 
shown an increased risk of incidence (up to 18 times) 
in association with breast implants for augmentation 
[3]. An increased risk of malignant T - cell lymphoma 
in patients with atopic dermatitis has also been 
reported [4]. The disease more often affects young 
and middle-aged adults, with mild male predominance 
and with rapid progression and generalisation [4]. The 
cutaneous involvement can be primary or secondary 
within systemic ALCL [2], resembling inflammatory 
and other neoplastic lesions both clinically and 
cytologically [1]. Although fine needle biopsy 
aspiration cytology is usually useful for the correct 
diagnosis, most of the cases present in advanced 
stages and usually have been excited regarding the 
wide spectrum of differential diagnosis [2][3]. 
 
 
Case Report 
 
A 63 – year - old male patient presented to 
the department of dermatologic surgery, because of 
an elevated violet tumor-like formation on the inner 
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side of his right hip. The lesion occurred 
approximately 20 days ago, accompanied by 
occasional spontaneous bleeding and mild discomfort. 
The patient had been treated with topical antibiotics 
for almost ten days, without any therapeutic result. 
Neither family history, not comorbidities were 
reported.  
Clinical examination revealed a nodular 
tumour-like formation with erythematous-violet 
discolouration, located on the medial side of the right 
hip (Fig. 1a). Enlarged lymph nodes were not detected 
on palpation. Laboratory blood tests were within the 
normal range. The patient was referred for surgical 
removal of the lesion. Elliptic surgical excision with 0.5 
cm surgical margins was performed under local 
anaesthesia (Fig.1 b, c, d).  
The histopathological examination of a 
fragment of the excited lesion revealed diffuse dermal 
infiltrate of atypical cells. The atypical cells were with 
prominent, centrally located nuclei. Simultaneously a 
mixed inflammatory infiltrates also detectable at the 
histology slides (Fig. 1 g, h, i). The findings were 
indicative of primary cutaneous anaplastic large T - 
cell lymphoma.  
 
Figure 1: a – Clinical manifestation of a primary cutaneous 
anaplastic large cell lymphoma, presented as a single violet nodule 
in the medial aspect of the right hip; b, c, d, e, f – Intraoperative 
findings. Surgical excision of the lesion; g, h, f – Histological 
findings. Diffuse dermal infiltrate of atypical cells with prominent 
centrally located nuclei, with simultaneously presented mixed 
inflammatory infiltrate 
 
The patient was referred for hospitalization in 
the haematology department for further screening for 
systemic involvement, which was not detected at this 
stage. Additional immunohistochemistry was planned 
for confirmation of the diagnosis, as well as spinal 
punction and serum flow cytometry.  
 
 
Discussion 
 
Primary cutaneous ALCL can be present 
clinically as single or multifocal nodules that ulcerate 
spontaneously, have autoregressive behavior and 
high rate of recurrence [5]. Regional lymph node 
invasion could be a sign for extracutaneous 
dissemination [5]. The diagnosis is confirmed by 
histological features such as diffuse, non-
epidermotropic infiltrate, and anaplastic large 
lymphoid cells of immunohistochemistry CD30+, 
CD4+, EMA-/+, ALK-, CD15- and TIA1-/+. [5]. Surgical 
removal of the lesion, radiotherapy or low-dose 
methotrexate is reported treatment of choices [5]. 
In the presented case, a clinically unspecific 
single violet nodular lesion was the only clinical 
manifestation of ALCL. Diagnosis was confirmed 
histologically, and surgical excision was enough 
therapeutic management in regard to the early 
disease stage. Prognosis is good and does not 
depend on lymphatic invasion in general. Further 
following up of the patient is mandatory because of 
the high recurrence rate [1]. 
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